HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Apurvasena Parikh Selected Research

telisotuzumab vedotin

11/2021Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, Monotherapy in Patients with Advanced Non-Small Cell Lung Carcinoma.
1/2021Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors.
11/2018First-in-Human Phase I, Dose-Escalation and -Expansion Study of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, in Patients With Advanced Solid Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Apurvasena Parikh Research Topics

Disease

3Neoplasms (Cancer)
01/2021 - 11/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 11/2021
1Disease Progression
02/2022
1Squamous Cell Carcinoma of Head and Neck
02/2022
1Nausea
01/2021
1Hypoalbuminemia
01/2021
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021
1Leiomyoma (Uterine Fibroids)
12/2020
1Menorrhagia
12/2020
1Pain (Aches)
12/2020
1Endometriosis
12/2020
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2018
1Infections
10/2016
1Hepatitis C
10/2016
1Sickle Cell Anemia (Hemoglobin S Disease)
11/2011

Drug/Important Bio-Agent (IBA)

3budigalimabIBA
02/2022 - 01/2021
3telisotuzumab vedotinIBA
11/2021 - 11/2018
3Immunoconjugates (Immunoconjugate)IBA
11/2021 - 11/2018
1LigandsIBA
02/2022
1rovalpituzumab tesirineIBA
01/2021
1Aligeron (AS 2)IBA
01/2021
1Programmed Cell Death 1 ReceptorIBA
01/2021
1Estradiol (Delestrogen)FDA LinkGeneric
12/2020
1Norethindrone Acetate (Norlutate)FDA LinkGeneric
12/2020
1LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
12/2020
1elagolixIBA
12/2020
1venetoclaxIBA
01/2018
1Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2016
1Tacrolimus (Prograf)FDA LinkGeneric
10/2016
1Antiviral Agents (Antivirals)IBA
10/2016
1vanillinIBA
11/2011

Therapy/Procedure

1Duration of Therapy
02/2022
1Liver Transplantation
10/2016